bullish

Vivos Therapeutics, Inc.: Strong 4Q; Solid Foundation for Growth in 2025

241 Views04 Apr 2025 08:47
Issuer-paid
Product revenue growth driven by lower discounts and higher guide sales. Vivos reported strong 4Q24 product revenue of $2.3 million, up 16% Q/Q and 52% Y/Y.
What is covered in the Full Insight:
  • Product Revenue Growth
  • Rebis Health Alliance
  • Medical-Based Marketing Model
  • M&A Team and Sleep Clinics
  • Financial Overview
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 10-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x